Aldeyra Therapeutics, Inc.
Company Stats
- Market Cap
- $74.2M
- as of Sep 30, 2026
- Shares Outstanding
- 60.3M
- Free Float
- 78.5%
Income Statement
- Operating Income
- -$35.3M
- Net Income
- -$33.8M
- EBITDA
- -$35.0M
Balance Sheet
- Cash & Equivalents
- $70.0M
Returns & Capital
- SBC, 3Y Avg
- $6.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2023 | — | -$30.3M | — |
| FY2022 | — | -$56.7M | — |
| FY2021 | — | -$42.6M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.